Reading room · November 7, 2026
Read a historical approval with its qualifiers
Keep the product, population and indication attached to an older sermorelin record so it cannot be mistaken for approval of a current compounded wellness preparation.
Educational and promotional content. CoreAge Rx is a featured commercial provider. No independent medical review or firsthand product testing is claimed.
Identify the product named in the record
The FDA record concerns an older sermorelin product called Geref. Read that product identity as part of the evidence, not as an optional detail to remove from a summary. A historical approval belongs to the product and conditions described in the record. Using only the ingredient name can make the finding appear broader than it is and blur its relationship to a present-day commercial offering.
Preserve the indication and population
The record identifies a pediatric growth-hormone-deficiency indication. That context does not establish approval for adult wellness or anti-aging uses. A sentence that keeps the ingredient name but drops the population and indication changes the meaning of the source. When a claim relies on the older record, ask whether those qualifiers are still visible and whether the claim stays within what the record actually describes.
Return to the preparation being considered now
CoreAge Rx describes its offered sermorelin preparation as compounded. Compounded drugs do not receive FDA premarket approval, and the older Geref record does not change that status. Ask the clinician to explain the specific proposed preparation and evidence relevant to the intended use. The historical source can clarify terminology, but it cannot substitute for a current product-specific discussion or establish that treatment is appropriate for you.